The project NOMED-AF aims to develop monitoring system based on telemedicine technology capable of discovering atrial fibrillation (AF) and applying the system in calculating AF incidence in 65+ population in Poland. Ischaemic stroke is one of the most common causes of death and disablement and its treatment constitutes a significant part of the costs of healthcare. AF is a known risk factor in ischaemic stroke. Anticoagulation therapy reduces the risk of embolic stroke. Many cases of atrial fibrillation remain undiscovered. It is estimated that 20-30% of strokes of non-defined etiology are caused by atrial fibrillation. The project’s objective is to solve the problem.
First phase of the project has  been dedicated to the development of a diagnostic device capable of discovering atrial fibrillation. In the second phase, the device has been validated in order to estimate its sensitivity and specificity in discovering AF in a population of patients with implanted ICD. The last phase of the project will consist of epidemiological survey measuring the incidence of AF in high-risk population.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    I consent to the processing of my personal data by Śląski Park Technologii Medycznych Kardio-Med Silesia Sp. z o.o., 10C M. Curie-Skłodowskiej St., 41-800 Zabrze, KRS:0000396540, NIP:6482761515, Regon:242742607, as Data Controler in order to receive a response. I can withdraw my consent by submitting a statement to: The Data Controler has notified me that this consent does not affect the legality of the processing carried out on the basis of consent before its withdrawal.

    The information clause on the details of the processing is available here.

    Supporting partners: